{'52WeekChange': -0.4770642,
 'SandP52WeekChange': 0.0644362,
 'address1': '141 Portland Street',
 'address2': 'Fifth Floor',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.86,
 'askSize': 1000,
 'averageDailyVolume10Day': 220200,
 'averageVolume': 345203,
 'averageVolume10days': 220200,
 'beta': 1.263537,
 'beta3Year': None,
 'bid': 2.63,
 'bidSize': 900,
 'bookValue': 1.225,
 'category': None,
 'circulatingSupply': None,
 'city': 'Cambridge',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 2.92,
 'dayLow': 2.81,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -0.762,
 'enterpriseToRevenue': None,
 'enterpriseValue': 84328560,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 3.030857,
 'fiftyTwoWeekHigh': 13.58,
 'fiftyTwoWeekLow': 1.96,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 19877214,
 'forwardEps': -0.9,
 'forwardPE': -3.1666667,
 'fromCurrency': None,
 'fullTimeEmployees': 121,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.29862,
 'heldPercentInstitutions': 0.58094,
 'industry': 'Drug Manufacturers—Specialty & Generic',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/solidbio.com',
 'longBusinessSummary': 'Solid Biosciences Inc., a life science company, '
                        'engages in identifying and developing therapies for '
                        'duchenne muscular dystrophy (DMD) in the United '
                        "States. The company's lead product candidate is "
                        'SGT-001, an adeno-associated viral vector-mediated '
                        'gene transfer, which is in a Phase I/II clinical '
                        'trial to restore functional dystrophin protein '
                        "expression in patients' muscles. Its portfolio also "
                        'comprises Anti-LTBP4, a monoclonal antibody that is '
                        'in preclinical trials to reduce fibrosis and '
                        'inflammation. In addition, the company engages in '
                        'developing biomarkers and sensors; and Solid Suit '
                        'program that includes the development of wearable '
                        'assistive devices that focus on providing functional '
                        'and therapeutic benefits to DMD patients. Solid '
                        'Biosciences Inc. was founded in 2013 and is '
                        'headquartered in Cambridge, Massachusetts.',
 'longName': 'Solid Biosciences Inc.',
 'market': 'us_market',
 'marketCap': 131301488,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_315986912',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -114335000,
 'nextFiscalYearEnd': 1640908800,
 'open': 2.92,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '617-337-4680',
 'previousClose': 2.92,
 'priceHint': 4,
 'priceToBook': 2.3265305,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 2.92,
 'regularMarketDayLow': 2.81,
 'regularMarketOpen': 2.92,
 'regularMarketPreviousClose': 2.92,
 'regularMarketPrice': 2.92,
 'regularMarketVolume': 163536,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 46070700,
 'sharesPercentSharesOut': 0.049000002,
 'sharesShort': 2256858,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1674185,
 'shortName': 'Solid Biosciences Inc.',
 'shortPercentOfFloat': 0.0922,
 'shortRatio': 5.6,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'SLDB',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -2.622,
 'twoHundredDayAverage': 2.9911222,
 'volume': 163536,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.solidbio.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02139'}